ATE229970T1 - Verfahren zur herstellung von mometason furoat - Google Patents

Verfahren zur herstellung von mometason furoat

Info

Publication number
ATE229970T1
ATE229970T1 AT99308380T AT99308380T ATE229970T1 AT E229970 T1 ATE229970 T1 AT E229970T1 AT 99308380 T AT99308380 T AT 99308380T AT 99308380 T AT99308380 T AT 99308380T AT E229970 T1 ATE229970 T1 AT E229970T1
Authority
AT
Austria
Prior art keywords
producing
furoate
mometason
mometasone
mometason furoate
Prior art date
Application number
AT99308380T
Other languages
English (en)
Inventor
William Dr Heggie
Joao Bandarra
Original Assignee
Hovione Int Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hovione Int Ltd filed Critical Hovione Int Ltd
Application granted granted Critical
Publication of ATE229970T1 publication Critical patent/ATE229970T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J17/00Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/38Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/44Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT99308380T 1999-08-02 1999-10-25 Verfahren zur herstellung von mometason furoat ATE229970T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PT102343A PT102343B (pt) 1999-08-02 1999-08-02 Processo para a preparacao de furoato mometasona

Publications (1)

Publication Number Publication Date
ATE229970T1 true ATE229970T1 (de) 2003-01-15

Family

ID=20085881

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99308380T ATE229970T1 (de) 1999-08-02 1999-10-25 Verfahren zur herstellung von mometason furoat

Country Status (22)

Country Link
US (1) US6177560B1 (de)
EP (1) EP1074558B1 (de)
JP (1) JP3746174B2 (de)
KR (1) KR100640066B1 (de)
CN (1) CN1149222C (de)
AT (1) ATE229970T1 (de)
AU (1) AU765592B2 (de)
CA (1) CA2295455C (de)
DE (1) DE69904585T2 (de)
DK (1) DK1074558T3 (de)
ES (1) ES2189354T3 (de)
HR (1) HRP990341B1 (de)
HU (1) HU227494B1 (de)
IL (1) IL133752A (de)
NO (1) NO321154B1 (de)
NZ (1) NZ500555A (de)
PL (1) PL191103B1 (de)
PT (1) PT102343B (de)
RU (1) RU2208616C2 (de)
SI (1) SI1074558T1 (de)
UA (1) UA60333C2 (de)
ZA (1) ZA996758B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070099883A1 (en) * 2005-10-07 2007-05-03 Cheryl Lynn Calis Anhydrous mometasone furoate formulation
EP1790754A1 (de) * 2005-11-24 2007-05-30 Siemens Aktiengesellschaft Schichtsystem mit Gadolinium-Mischkristall-Pyrochlorphase
US8021742B2 (en) * 2006-12-15 2011-09-20 Siemens Energy, Inc. Impact resistant thermal barrier coating system
US8815258B2 (en) 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
PL3111927T3 (pl) * 2009-05-29 2020-06-29 Pearl Therapeutics, Inc. Kompozycje do wziewnego podawania środków aktywnych oraz związane z nimi sposoby i systemy
PT105139B (pt) * 2010-06-01 2013-01-29 Hovione Farmaciencia S A Método para a monofluorometilação de substratos orgânicos para preparação de compostos orgânicos biologicamente activos
SG11201507286QA (en) 2013-03-15 2015-10-29 Pearl Therapeutics Inc Methods and systems for conditioning of particulate crystalline materials
US20150150787A1 (en) 2013-05-22 2015-06-04 Pearl Therapeutics, Inc. Compositions, methods & systems for respiratory delivery of three or more active agents
CN105481933B (zh) * 2015-12-25 2017-09-19 山东京卫制药有限公司 一种合成糠酸莫米松的方法
CN105566437B (zh) * 2015-12-30 2018-07-20 山东京卫制药有限公司 一种8dm衍生物及利用其合成糠酸莫米松的方法
CN107266518B (zh) * 2016-04-08 2021-03-30 天津金耀集团有限公司 一种糠酸莫米松晶型及其制备方法
CA3226557A1 (en) 2021-07-09 2023-01-12 Astrazeneca Pharmaceuticals Lp Compositions, methods and systems for aerosol drug delivery
EP4452230A1 (de) 2021-12-20 2024-10-30 Astrazeneca AB Zusammensetzungen, verfahren und systeme zur aerosolwirkstofffreisetzung

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CY1359A (en) * 1981-02-02 1987-08-07 Schering Corp Aromatic heterocyclic esters of steroids, their preparation and pharmaceutical compositions containing them
CA2258681C (en) * 1996-06-28 2006-11-14 Schering Corporation Process for the preparation of 17-esters of 9.alpha.,21-dihalo-pregnane-11.beta.,17.alpha.diol-20-ones
US5886200A (en) * 1996-07-01 1999-03-23 Schering Corporation Process for the preparation of 17-esters of 9 α, 21-dihalo-pregnane-11 β, 17 α-diol-20-ones

Also Published As

Publication number Publication date
ZA996758B (en) 2000-08-30
ES2189354T3 (es) 2003-07-01
PL191103B1 (pl) 2006-03-31
KR100640066B1 (ko) 2006-10-31
JP3746174B2 (ja) 2006-02-15
JP2001048897A (ja) 2001-02-20
RU2208616C2 (ru) 2003-07-20
NO995225L (no) 2001-02-05
SI1074558T1 (en) 2003-04-30
KR20010020094A (ko) 2001-03-15
PT102343A (pt) 2001-02-28
AU765592B2 (en) 2003-09-25
PT102343B (pt) 2003-11-28
NZ500555A (en) 2000-11-24
CN1282744A (zh) 2001-02-07
CA2295455A1 (en) 2001-02-02
AU5602499A (en) 2001-02-08
EP1074558A1 (de) 2001-02-07
US6177560B1 (en) 2001-01-23
NO995225D0 (no) 1999-10-26
PL336452A1 (en) 2001-02-12
CA2295455C (en) 2008-03-25
NO321154B1 (no) 2006-03-27
EP1074558B1 (de) 2002-12-18
HUP9903747A3 (en) 2001-07-30
DK1074558T3 (da) 2003-04-07
HU227494B1 (en) 2011-07-28
UA60333C2 (uk) 2003-10-15
CN1149222C (zh) 2004-05-12
IL133752A0 (en) 2001-04-30
HUP9903747A2 (hu) 2001-05-28
HRP990341B1 (en) 2003-10-31
HU9903747D0 (en) 1999-12-28
IL133752A (en) 2004-02-19
DE69904585T2 (de) 2003-05-15
DE69904585D1 (de) 2003-01-30
HRP990341A2 (en) 2001-04-30

Similar Documents

Publication Publication Date Title
DE69907037T2 (de) Verfahren zur herstellung von citalopram
ATA904099A (de) Verfahren zur herstellung von citalopram
ATE235478T1 (de) Verfahren zur herstellung von citalopram
DE69332310D1 (de) Verfahren zur herstellung von vorgefüllten, sterilen abgabevorrichtungen.
EP0677100A4 (de) Verfahren zur herstellung von neuroblasten.
ATE324885T1 (de) Verfahren zur herstellung von fenofibrathaltigen arzneizusammensetzungen mit erhöhter bioverfügbarkeit
ATE229970T1 (de) Verfahren zur herstellung von mometason furoat
ATE232855T1 (de) Verfahren zur herstellung von derivaten der taxoid-klasse
ATE222900T1 (de) Verfahren zur herstellung von 5-cyanophthalid
DE69407624D1 (de) Verfahren zur herstellung von sialon-verbundwerkstoffen
DE69021341D1 (de) Härtungsmittel, verfahren zu seiner herstellung und damit hergestellte härtbare zusammensetzung.
ATE262576T1 (de) Verfahren zur herstellung von weichmittelzusammensetzungen
DE59402555D1 (de) Verfahren zur herstellung von epoxysiloxanen
DE69313297D1 (de) Benzofuranone, benzodifurantrione und verfahren zur herstellung von benzodifurandionen
DE69920526D1 (de) Verfahren zur herstellung von citalopram
DE59803655D1 (de) Verfahren zur herstellung von aliphatischen alpha, omega-aminonitrilen
ATE267839T1 (de) Verfahren zur herstellung von cyclo-(asp-dphe- nmeval-arg-gly)
DE59611076D1 (de) Verfahren zur herstellung von 5,6-dihydro-1,3-oxazinen
DE69000827D1 (de) Verfahren zur herstellung von aminoxiden.
ATE295349T1 (de) Verfahren zur herstellung von ketiminen
DE69708126D1 (de) Verfahren zur herstellung von paclitaxel
DE68914838D1 (de) Verfahren zur herstellung von karbiden und siliciden auf mechanochemischem weg.
DE60015944D1 (de) Verfahren zur herstellung von alpha-methylenelactonen und alpha-substitutierten hydrocarbyliden-lactonen
DE59903196D1 (de) Verfahren zur herstellung von langnachleuchtenden sicherheitsmarkierungen, sicherheitsschildern und dergleichen
DE59506919D1 (de) Verfahren zur herstellung von aliphatischen alpha,omega-aminonitrilen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1074558

Country of ref document: EP